Methadone prescribing under supervised consumption on premises: A Scottish clinician's perspective on prescribing practice

Drug and Alcohol Review

Volumn 31, Issue 3, 2012, Pages 342-347

  Anthony, Geraldine B ^a   Matheson, Catriona I ^a   Holland, Richard ^b   Bond, Christine ^a   Roberts, Kennedy ^c   Rae, Anne Mac ^d   Whitelaw, Eddie ^c   Priyadarshi, Saket ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Drug misuse; Methadone; Pharmacy; Supervision

Indexed keywords

EID: 84860152219     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2011.00316.x     Document Type: Article

References (18)

1. Drug Misuse Statistics Scotland. 2008. Available at: (accessed 1 Jun 2009).
2. Morgan O, Griffiths C, Hickman M. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int J Epidemiol 2006;35:1579-85.
3. Weinrich M, Stuart M. provision of methadone treatment in primary medical care practices: review of the Scottish experience and implications for US policy. JAMA 2003;283:1343-8.
4. National Treatment Agency. Numbers receiving drug treatment in England. [Web Page]. 2006. Available at: (accessed 20 May 2011).
5. Peterkin T. Cost of methadone prescriptions up by 84 per cent in five years. Scotsman.com news, April 2010.
6. Advisory Council on the Misuse of Drugs. Reducing drug related deaths. London: Stationery Office, 2000.
7. Matheson C, Bond CM, Tinelli M. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland. J Public Health 2007;29:350-7.
8. Departments of Health. Drug misuse and dependence: guidelines on clinical management. London: The Stationery Office, 2007.
9. Green H, James RA, Gilbert JD, Harpas P, Byard RW. Methadone maintenance programs-a two-edged sword? [Review][20 refs]. Am J Forensic Med Pathol 2000;21:359-61.
10. National Institute for Clinical Excellence. London: NICE, 2002. Available at: (accessed 20 May 2011).
11. National Prescribing Centre & National Primary Care Research and Development Centre. Medicines management. Liverpool: NPC, NPCDC, 2002.
12. Shooter M. The patients' perspective on medicines in mental health. Br Med J 2003;327:824-6.
13. Cameron I, Naji S, Mc Keganey N. A survey of NHS Services for opiate dependents in Scotland. Report to the Effective Interventions Unit, Scottish Executive, Edinburgh. 2001.
14. Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1998;88:34-9.
15. Bell J, Shanahan M, Mutch C, etal. A randomised trial of effectiveness and cost-effectiveness of observed administration of buprenorphine-naloxone for heroin dependence. Addiction 2007;102(12):1899-977.
16. The Scottish Government. The road to recovery. A new approach to tackling Scottish drug problem. Edinburgh: The Scottish Government, 2008. Available at: (accessed 20 May 2011).
17. Scotland's Future Forums. Approaches to alcohol and drugs in Scotland. 2007/8. Available at: (accessed 20 May 2011).
18. National Institute for Health and Clinical Excellence (NICE). Methadone and buprenorphine for the management of opioid dependence (Technology appraisal guidance no. 114). London: NICE, 2007.